|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.612
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.563
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.525
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.446
|
Human |
|
|
epidermis development
|
GO:0008544 |
187 |
0.423
|
Human |
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.422
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.373
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.367
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.328
|
Human |
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.326
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.302
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.292
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.275
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.265
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.264
|
Human |
|
|
membrane organization
|
GO:0061024 |
245 |
0.259
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.254
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.241
|
|
|
|
tumor necrosis factor mediated signaling pathway
|
GO:0033209 |
13 |
0.238
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.235
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.232
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.209
|
Human |
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.203
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.201
|
Human |
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.193
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.186
|
Human |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.179
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.165
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.165
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.161
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.159
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.155
|
Human |
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.153
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.150
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.145
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.143
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.141
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.135
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.132
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.132
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.127
|
Human |
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.126
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.126
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.125
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.124
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.123
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.121
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.120
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.119
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.119
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.116
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.115
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.114
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.112
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.111
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.111
|
|
|
|
intermediate filament organization
|
GO:0045109 |
15 |
0.110
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.110
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.110
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.108
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.108
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.103
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.102
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.102
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.100
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.098
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.097
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.096
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.095
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.094
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.094
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.094
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.094
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.092
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.092
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.091
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.090
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.090
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.089
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.088
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.088
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.088
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.087
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.086
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.086
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.085
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.085
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.084
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.084
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.083
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.083
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.082
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.082
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.082
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.081
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.081
|
|
|
|
regulation of hair follicle development
|
GO:0051797 |
9 |
0.081
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.080
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.079
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.079
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.079
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.078
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.078
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.077
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.077
|
|
|
|
keratinization
|
GO:0031424 |
9 |
0.077
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.077
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.076
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.075
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.075
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.074
|
|
|
|
positive regulation of hair follicle development
|
GO:0051798 |
6 |
0.074
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.074
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.073
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.073
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.072
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.072
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.072
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.072
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.071
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.071
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.071
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.070
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.069
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.069
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.068
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.068
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.068
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.068
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.068
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.068
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.068
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.067
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.067
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.065
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.065
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.065
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.065
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.064
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.064
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.064
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.063
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.063
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.063
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.062
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.062
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.062
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.061
|
|
|
|
regulation of hair cycle
|
GO:0042634 |
11 |
0.061
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.060
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.060
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.059
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.059
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.059
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.058
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.057
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.057
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.057
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.056
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.056
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.056
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.056
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.055
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.055
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.055
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.055
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.055
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.055
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.054
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.054
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.054
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.054
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.052
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.052
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.052
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.052
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.051
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.051
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.051
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.051
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.051
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.051
|
|
|
|
positive regulation of epidermis development
|
GO:0045684 |
13 |
0.051
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.050
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.050
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.050
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.050
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.050
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.050
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.050
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.050
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.050
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.050
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.049
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.049
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.049
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.049
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.048
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.048
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.048
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.048
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.047
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.047
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.047
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.047
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.047
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.047
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.046
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.046
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.046
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.045
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.045
|
Human |
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.045
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.044
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.044
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.044
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.044
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.044
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.044
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
16 |
0.043
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.043
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.043
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.043
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.043
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.042
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.042
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.042
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.042
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.042
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.041
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.041
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.041
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.040
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.040
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.040
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.040
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.040
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.040
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.040
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.040
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.040
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.040
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.040
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.039
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.039
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.039
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.039
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.039
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.039
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.039
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
21 |
0.039
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.039
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.039
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.038
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.038
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.038
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.038
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.038
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.038
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.038
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.038
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.038
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.037
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.037
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.037
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.037
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.037
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.037
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.037
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.037
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.037
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.037
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.036
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.036
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.036
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.036
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.036
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.036
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.036
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.036
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.036
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.035
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.035
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.035
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.035
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.035
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.035
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.035
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.035
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.035
|
Mouse |
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.035
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.035
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.034
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.034
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.034
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.034
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.034
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.034
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.034
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.034
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.034
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.034
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.034
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.034
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.033
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.033
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.033
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.033
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.033
|
|
|
|
regulation of interleukin 1 beta production
|
GO:0032651 |
25 |
0.033
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.033
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.033
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.033
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.032
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.032
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.032
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.032
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.032
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.032
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.032
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.032
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.032
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.032
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.032
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.032
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.032
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.032
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.032
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.032
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.031
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.031
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.031
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.031
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.031
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.031
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.031
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.031
|
|
|
|
endodermal digestive tract morphogenesis
|
GO:0061031 |
4 |
0.031
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.031
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.030
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.030
|
|
|
|
olfactory bulb interneuron differentiation
|
GO:0021889 |
12 |
0.030
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.030
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.030
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.030
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.030
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.030
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.030
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.030
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.029
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.029
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
40 |
0.029
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.029
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.029
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.029
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.029
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.028
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.028
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.028
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.028
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.028
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.028
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.028
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.028
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.028
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.028
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.028
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.028
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.028
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.028
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.028
|
|
|
|
positive regulation of interleukin 6 production
|
GO:0032755 |
37 |
0.028
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.028
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.028
|
|
|
|
loop of henle development
|
GO:0072070 |
10 |
0.028
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.028
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.027
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.027
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.027
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.027
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.027
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.027
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.027
|
|
|
|
paraxial mesoderm development
|
GO:0048339 |
18 |
0.027
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.027
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.027
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.027
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.027
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.027
|
|
|
|
regulation of branching involved in salivary gland morphogenesis
|
GO:0060693 |
11 |
0.027
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.027
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.027
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.027
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.027
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.026
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.026
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.026
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.026
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.026
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.026
|
|
|
|
intestinal epithelial cell maturation
|
GO:0060574 |
2 |
0.026
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.026
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.026
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.026
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.026
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.026
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.026
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.026
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.026
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.026
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.026
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.026
|
|
|
|
mesenchymal epithelial cell signaling
|
GO:0060638 |
9 |
0.026
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.026
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.026
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.026
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.025
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.025
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.025
|
|
|
|
metanephric renal vesicle morphogenesis
|
GO:0072283 |
12 |
0.025
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.025
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.025
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.025
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.025
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.025
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.025
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.025
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.025
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.025
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.025
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.025
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.024
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.024
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.024
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.024
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.024
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.024
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.024
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.024
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.024
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.024
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.024
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.024
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.024
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.024
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.024
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.024
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.024
|
|
|
|
regulation of interleukin 1 secretion
|
GO:0050704 |
15 |
0.024
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.024
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.024
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.024
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.023
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.023
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.023
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.023
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.023
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.023
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.023
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.023
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.023
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.023
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.023
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.023
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.023
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.023
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.023
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.023
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
29 |
0.023
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.023
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.023
|
|
|
|
cartilage morphogenesis
|
GO:0060536 |
11 |
0.023
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.023
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.023
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.023
|
|
|
|
mammary gland epithelial cell proliferation
|
GO:0033598 |
24 |
0.023
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.022
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.022
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.022
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.022
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.022
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.022
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.022
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.022
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.022
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.022
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.022
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.022
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.022
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.022
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.022
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.022
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.022
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.022
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.022
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.022
|
|
